Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/9/2017
SIETES contiene 92006 citas

 
 
 1 a 20 de 155 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Riesgo de formación de depósitos cerebrales asociado a la administración de agentes de contraste con gadolinio. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2017:1-3. [Ref.ID 101459]
2. Cita con resumen
Whitehead KJ, Sautter NB, McWilliams JP, Chakinala MM, Merlo CA, Johnson MH, James M, Everett EM, Clancy MS, Faughnan ME, Oh SP, Olitsky SE, Pyeritz RE, Gossage JR. Effect of topical intranasal therapy on epistaxis frequency in patients with heraditary hemorrhagic telangiectasia: a randomized clinical trial. JAMA 2016;316:943-51. [Ref.ID 100742]
3.Enlace a cita original Cita con resumen
Anónimo. Metformin-containing drugs: drug safety communication - Revised warnings for certain patients with reduced kidney function. FDA U.S. Food and Drug Administration 2016:8 de abril. [Ref.ID 100111]
4. Cita con resumen
Hesdorffer CS, Longo DL. Drug-induced megaloblastic anemia. N Engl J Med 2015;373:1649-58. [Ref.ID 99629]
5. Cita con resumen
Quintavalle C, Fiore D, De Micco F, Visconti G, Focaccio A, Golia B, Ricciardelli B, Donnarumma E, Bianco A, Zabatta MA, Troncone G, Colombo A, Briguori C, Condorelli G. Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation 2012;126:3008-16. [Ref.ID 94308]
6. Cita con resumen
Anónimo. Florbetapir 18F: approved for neuritic plaque density imaging. European Union. WHO Drug Information 2012;26:387-8. [Ref.ID 93818]
7. Cita con resumen
Lövborg H, Eriksson LR, Jönsson AK, Bradley T, Hägg S. A prospective analysis of the preventability of adverse drug reactions reported in Sweden. Eur J Clin Pharmacol 2012;68:1183-9. [Ref.ID 93517]
8. Cita con resumen
Chang HJ. Researchers focus on contrast safety. JAMA 2010;303:1244. [Ref.ID 88256]
9.
Khachman D, Gandia P, Sallerin F, Mailly N. Mise au point sur les réactions d'hypersensibilité immédiate et tardive aux produits de contraste iodés. Therapie 2009;64:331-9. [Ref.ID 87449]
10. Cita con resumen
Anónimo. Metformine: encore des acidoses lactiques évitables. Prescrire 2009;29:832. [Ref.ID 87148]
11. Cita con resumen
Lee CU, Hesley GK, Leung N, Bridges MD, Lund JT, Lee PU, Pittelkow MR. Large sample of nephrogenic systemic fibrosis cases from a single institution. Arch Dermatol 2009;145:1095-102. [Ref.ID 87068]
12. Cita con resumen
Abujudeh HH, Kaewlai R, Kagan A, Chibnik LB, Nazarian RM, High WA, Kay J. Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: Case series of 36 patients. Radiology 2009;253:81-9. [Ref.ID 87067]
13. Cita con resumen
Naughton C. Drug-induced nephrotoxcicity. American Family Physician 2008;78:743-50. [Ref.ID 87065]
14. Cita con resumen
Zoungas S, Ninomiya T, Huxley R, Cass A, Jardine M, Gallagher M, Patel A, Vasheghani-Farahani A, Sadigh G, Perkovic V. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med 2009;151:631-8. [Ref.ID 87053]
15. Cita con resumen
Anónimo. Insuffisances rénales d'origine médicamenteuse. Prescrire 2009;29:506-10. [Ref.ID 86213]
17. Cita con resumen
Baid SK, Lai EW, Wesley RA, Ling A, Timmers HJLM, Adams KT, Kozupa A, Pacak K. Brief communication: radiographic contrast infusion and catecholamine release in patients with pheochromocytoma. Ann Intern Med 2009;150:27-32. [Ref.ID 85011]
18. Cita con resumen
Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Bellandi F. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 2008;52:599-604. [Ref.ID 84029]
19. Cita con resumen
Lapi F, Cecchi E, Pedone C, Attanasio F, Banchelli G, Vannacci A, Di Pirro M, Moschini M, Berni V, Matucci R, Cini E, Scalia A, Tendi E, Mugelli A. Safety aspects of iodinated contrast media related to their psychochemical properties: a pharmacoepidemiology study in two Tuscany hospitals. Eur J Clin Pharmacol 2008;64:723-37. [Ref.ID 83517]
20. Cita con resumen
Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 2008;148:284-94. [Ref.ID 82249]
Seleccionar todas
 
 1 a 20 de 155 siguiente >>